Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation

Pediatric Transplantation

Volumn 6, Issue 2, 2002, Pages 111-118

  Robinson, Lisa Gaye ^a   Hilinski, Joseph ^a   Graham, Fitzroy ^a   Hymes, Leonard ^a   Beck Sague, Consuelo M ^a,b,c   Hsia, Jason ^c   Nesheim, Steven R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cytomegalovirus; Opportunistic infections; Renal transplantation; Seasonality

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; GANCICLOVIR; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CADAVER KIDNEY; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREDICTION; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SERODIAGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTIONS; PEDIATRICS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROBABILITY; REGISTRIES; RISK FACTORS; SAMPLING STUDIES; SEASONS; TIME FACTORS;

EID: 0036256499     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.01049.x     Document Type: Article

References (31)

1. Cytomegalovirus infection - An etiological factor for rejection?
2. Cytomegalovirus infections following renal transplantation - Effects ofantiviral prophylaxis: A report of North American Pediatric Renal Transplant Cooperative Study
3. Prophylaxis and treatment of CMV infection in transplantation
4. Effect of antithymocyte globulin induction treatment on renal transplant on renal transplant outcome
5. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus diseases in liver transplantation
6. Mycophenolate mofetil for maintenance therapy in kidney transplantation
7. The use of mycophenolate mofetil in renal transplantation
8. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses
9. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?
10. Definitions of cytomegalovirus infection and disease
11. Cytomegalovirus prophylaxis in antibody-treated renal transplanted patients
12. Prospective cytomegalovirus surveillance in paediatric renal transplant patients
13. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients
14. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation
15. Clinical practice guidelines: Prevention of cytomegalovirus disease after renal transplantation
16. Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients
17. Cytomegalovirus prophylaxis in solid organ transplant recipients
18. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation
19. Management of cytomegalo-virus infection after solid-organ or stem-cell transplantation
20. Prophylaxis against herpes infection in kidney transplant patients with special emphasis on CMV
21. Comparison of ganciclovir and immune globulin-containing regimens in preventing cytomegalo-virus infection in patients with renal transplants
22. Viruses associated with acute lower respiratory tract infections in children from the eastern highlands of Papua New Guinea (1983-1985)
23. Primary infections of Epstein-Barr virus, cytomegalovirus, and human herpesvirus-6
24. A review of reported cytomegalovirus infections in Scotland during 1975
25. Parainfluenza virus type 3 infections: Findings in Sydney and some observations on variations in seasonality world-wide
26. Immunomodulation by viruses: The myxoma virus story
27. Transfusion of the HIV-seropositive patient: Immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4)m CMV (HHV-5) and HHV-7, 7, and 8
28. The human polymavirus BK T antigen induces gene expression in human cytomegalovirus
29. Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments